Patients with ischemic heart disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients with stable ischemic heart disease and LDL-C<100 mg/dL, and without treatment of eicosapentaenoic acid, who is under cardiac rehabilitation program
Exclusion criteria
Exclusion criteria: 1)no treatment of statin 2)treatment of eicosapentaenoic acid 3)Pregnant 4)allergic to study drug 5)severe liver disease 6)bleeding tendency or bleeding 7)not appropriate for this study by judgement of a physician
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in Flow Mediated Dilation after 3 months treatment | — |
Countries
Japan
Contacts
Okayama University Hospital Department of Cardiovascular Medicine